CN103611091A - Traditional Chinese medicine composition for treating pancreatic cancer - Google Patents

Traditional Chinese medicine composition for treating pancreatic cancer Download PDF

Info

Publication number
CN103611091A
CN103611091A CN201310669009.7A CN201310669009A CN103611091A CN 103611091 A CN103611091 A CN 103611091A CN 201310669009 A CN201310669009 A CN 201310669009A CN 103611091 A CN103611091 A CN 103611091A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
rhizoma
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310669009.7A
Other languages
Chinese (zh)
Other versions
CN103611091B (en
Inventor
王启凌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DONGGUAN SHENGHONG BIOTECHNOLOGY Co Ltd
Original Assignee
DONGGUAN SHENGHONG BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DONGGUAN SHENGHONG BIOTECHNOLOGY Co Ltd filed Critical DONGGUAN SHENGHONG BIOTECHNOLOGY Co Ltd
Priority to CN201310669009.7A priority Critical patent/CN103611091B/en
Publication of CN103611091A publication Critical patent/CN103611091A/en
Application granted granted Critical
Publication of CN103611091B publication Critical patent/CN103611091B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a traditional Chinese medicine composition for treating pancreatic cancer, and provides a medicine prepared by taking traditional Chinese medicinal materials as raw materials and used for treating pancreatic cancer, wherein the medicine is high in curative effect, obvious in symptom reduction, and capable of improving the living quality and survival rate of patients. The raw material medicines of the traditional Chinese medicine disclosed by the invention are composed of the following constituents: spina date seeds, astragalus membranaceus, codonopsis pilosula, bighead atractylodes rhizome, pearl barley, oldenlandia diffusa, poria cocos, akebia quinata DC, sculellaria barbata, salvia chinensis, polygala tenuifolia, liquorice, honewort, rhizoma cyperi, curcuma aromatica, fingered citron, Chinese lobelia, rhizoma corydalis, ligusticum wallichii, dried tangerine or orange peel, pinellia ternata, magnolia obavata, hedge glorybind flower, radix paeoniae alba and bletilla striata. The traditional Chinese medicine disclosed by the invention is mainly used for treating pancreatic cancer, has the characteristics of being fast in effect taking, good in curative effect, convenient to take, and the like, has the characteristic of being low in toxic and side effects compared with general chemical medicines, and has an obvious anticancer effect.

Description

A kind of Chinese medicine composition for the treatment of cancer of pancreas
Technical field
The invention belongs to Chinese medicine composition, be specifically related to a kind of Chinese medicine composition of the treatment cancer of pancreas being formed by the multiple Chinese herbal medicine with anticancer function.
Background technology
Cancer of pancreas is one of common malignant tumor, and the M & M of nearly many decades cancer of pancreas has the trend obviously increasing, and the M & M of cancer of pancreas rises rapidly, and this is a worldwide trend.The method for the treatment of cancer of pancreas has operation, chemotherapy, chemotherapy and radiotherapy at present.Surgical operation is one of most important means of cancer of pancreas Comprehensive Treatment always, and this method is mainly used in topical therapeutic, especially for early stage Small pancreatic carcinoma, and Patients with Subclinical Small pancreatic carcinoma.Although technology and the mode for the treatment of of pancreatic cancer make rapid progress, limited to the effect of raising survival rate, still unavoidably recurrence, because cancer is genopathy.Radiotherapy is for relatively early, and don't can tolerate operative treatment or tumor length is a kind of good Part Substitution treatment means in some treatments special, that be difficult to the position of excision.Chemotherapy is a kind of method of killing for potential metastatic lesion of whole body therapeutic, but because the toxic and side effects of chemotherapeutics is large, therefore this Therapeutic Method tends to people's immunity to eliminate.
The traditional Chinese medical science is regarded cancer of pancreas as a topical manifestations of systemic disease, emphasizes across-the-board regulation function of human body in treatment, passes through determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs.Chinese medicine energy Combined with Radiotherapy, chemotherapy attenuation synergistic can be accelerated postoperative rehabilitation after operation, and relieving the pain caused by diseases improves life quality.
Summary of the invention
The object of the invention is the defect existing in order to overcome prior art, deficiency for existing clinical antineoplaston, a kind of medicine of take the treatment cancer of pancreas that Chinese crude drug is waste is provided, and its curative effect is high, symptom alleviates obviously, can improve patients ' life quality and extend the time-to-live.
In order to realize object of the present invention, the present invention adopts following scheme:
Treat a Chinese medicine composition for cancer of pancreas, the crude drug of its Chinese medicine is comprised of the component of following weight parts proportioning:
240~270 parts of Semen Ziziphi Spinosaes, 100~115 parts of the Radixs Astragali, 100~115 parts of Radix Codonopsis, 65~80 parts of the Rhizoma Atractylodis Macrocephalaes, 100~115 parts of Semen Coicis core, 100~115 parts of Herba Hedyotidis Diffusaes, 75~85 parts, Poria, 75~85 parts of Fructus Akebiaes, 95~110 parts of Herba Scutellariae Barbataes, 75~85 parts of Herba Salviae Chinensiss, 60~75 parts of Radix Polygalaes, 20~25 parts, Radix Glycyrrhizae, 120~145 parts of Radix Bupleuris, 40~55 parts of Rhizoma Cyperis, 40~55 parts of Radix Curcumaes, 45~60 parts of Fructus Citri Sarcodactylis, 70~85 parts of Herba Lobeliae Chinensis, 45~60 parts of Rhizoma Corydalis, 25~30 parts of Rhizoma Chuanxiong, 14~19 parts of Pericarpium Citri Reticulataes, 100~115 parts of the Rhizoma Pinelliaes, 8~13 parts of Cortex Magnoliae Officinalis, 60~75 parts of Flos Calystegiae sepii, 28~35 parts of the Radix Paeoniae Albas, 65~80 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s.
In some embodiment, the crude drug of described Chinese medicine is comprised of the component of following weight parts proportioning therein:
260 parts of Semen Ziziphi Spinosaes, 105 parts of the Radixs Astragali, 105 parts of Radix Codonopsis, 70 parts of the Rhizoma Atractylodis Macrocephalaes, 105 parts of Semen Coicis core, 105 parts of Herba Hedyotidis Diffusaes, 84 parts, Poria, 84 parts of Fructus Akebiaes, 105 parts of Herba Scutellariae Barbataes, 84 parts of Herba Salviae Chinensiss, 70 parts of Radix Polygalaes, 21 parts, Radix Glycyrrhizae, 130 parts of Radix Bupleuris, 50 parts of Rhizoma Cyperis, 50 parts of Radix Curcumaes, 50 parts of Fructus Citri Sarcodactylis, 75 parts of Herba Lobeliae Chinensis, 50 parts of Rhizoma Corydalis, 30 parts of Rhizoma Chuanxiong, 16 parts of Pericarpium Citri Reticulataes, 110 parts of the Rhizoma Pinelliaes, 10 parts of Cortex Magnoliae Officinalis, 70 parts of Flos Calystegiae sepii, 30 parts of the Radix Paeoniae Albas, 70 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s.
Semen Ziziphi Spinosae: sweet, flat;
Cure mainly: restlessness of asrhenia type and insomnia; Palpitation with fear palpitation with a distress feeling; The empty spontaneous perspiration of body, night sweat.
The Radix Astragali: slightly warm in nature, sweet in the mouth.
Cure mainly: deficient qi and blood, spontaneous perspiration, chronic diarrhea proctoptosis, uterine prolapse, nephritis edema, albuminuria, diabetes, chronic ulcer.
Radix Codonopsis: sweet in the mouth, micro-acid, flat;
Cure mainly: invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.For deficiency of the spleen and lung, the cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency cough, interior-heat is quenched one's thirst.
The Rhizoma Atractylodis Macrocephalae: bitter, sweet, temperature;
Cure mainly: spleen reinforcing, stomach reinforcing, dampness, and in, antiabortive.Control deficient QI of the spleen and stomach, anorexia, asthenia weak breath, deficiency-distension, has loose bowels, phlegm retention, edema, jaundice, arthralgia chiefly caused by damp pathogen, dysuria, dizziness, spontaneous perspiration, nausea is uneasy.
Semen Coicis core: sweet, be slightly cold;
Cure mainly: main arthralgia chiefly caused by damp pathogen, sharp the intestines and stomach, consumer edema, diuresis and anticancer, beriberi edema, carcinoma initial stage.
Herba Hedyotidis Diffusae: bitter, light, cold in nature;
Cure mainly: heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.
Poria: sweet in the mouth is light flat;
Cure mainly: mind tranquilizing and the heart calming, relieves internal heat anticancer.Can control dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, malignant histocytosis, have loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, the disease such as forgetful.
Fructus Akebiae: bitter in the mouth, cold nature;
Cure mainly: the digestive system tumors such as hepatocarcinoma, gastric cancer, and pulmonary carcinoma, breast carcinoma etc.
Herba Scutellariae Barbatae: acrid in the mouth; Hardship, cold in nature;
Cure mainly: pyretic toxicity carbuncle; Have sore throat; Lung abscess; Intestinal carbuncle; Scrofula; Venom; Traumatic injury; Spit blood; Epistaxis; Stranguria with blood; Edema; Ascites and cancer.
Herba Salviae Chinensis: micro-hardship, flat;
Cure mainly: heat-clearing and toxic substances removing, invigorating blood circulation analgesia.For icterohepatitis, cancer, nephritis, leucorrhea, dysmenorrhea, tuberculous lymphadenitis, elephantiasis.
Radix Polygalae: bitter in the mouth, pungent;
Cure mainly: the function of there is the Fructus Alpiniae Oxyphyllae of calming the nerves, eliminate the phlegm, subsiding a swelling, the insomnia and dreamful sleep causing for disarmony between the heart and kidney, forgetful palpitation with fear, staring spells, expectoration is not well, sore swollen toxin, breast swell and pain.
Radix Glycyrrhizae: feeble QI, taste is sweet, and property is gentle;
Cure mainly: QI invigorating invigorating middle warmer; Relieving spasm to stop pain; Nourishing the lung to arrest cough; Eliminating fire and detoxication; Coordinating the actions of various ingredients in a prescription.
Radix Bupleuri: cold nature, bitter in the mouth;
Cure mainly: induce sweat bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, cure mainly the diseases such as alternate attack of chill and fever, breast side of body feeling of distension and oppression, malaria, menoxenia.
Rhizoma Cyperi: pungent micro-hardship is sweet, flat;
Cure mainly: stagnation of QI due to depression of the liver, breast, the side of body, abdominal distention,, dyspepsia, menoxenia, amenorrhea dysmenorrhea, colic of cold type stomachache, distending pain of the breast.
Radix Curcumae: pungent, bitter, cold;
Cure mainly: promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.For amenorrhea dysmenorrhea, chest and abdomen swelling and pain, twinge, calentura coma, epilepsy is gone mad, jaundice dark coloured urine.
Fructus Citri Sarcodactylis: pungent, bitter, sour, temperature;
Cure mainly: liver-smoothing, qi-regulating, and stomach and alleviating pain.For stagnation of liver-QI and stomach-QI, distending pain in the chest and hypochondrium, gastral cavilty feeling of fullness, lack of appetite vomiting.
Herba Scutellariae Barbatae: acrid in the mouth; Hardship, cold in nature;
Cure mainly: pyretic toxicity carbuncle; Have sore throat; Lung abscess; Intestinal carbuncle; Scrofula; Venom; Traumatic injury; Spit blood; Epistaxis; Stranguria with blood; Edema; Ascites and cancer.
Rhizoma Corydalis: warm in nature, acrid in the mouth is bitter;
Cure mainly: regulate the flow of vital energy, invigorate blood circulation, pain relieving.For the stomachache of qi depression to blood stasis, hypochondriac pain, headache and dysmenorrhea etc.
Rhizoma Chuanxiong: pungent, temperature;
Cure mainly: blood-activating and qi-promoting, wind-expelling pain-stopping.
Pericarpium Citri Reticulatae: warm in nature, acrid in the mouth, bitter in the mouth;
Cure mainly: regulating qi-flowing for strengthening spleen, in tune, dampness, reduces phlegm.Cure mainly the distension and fullness in the abdomen of stagnation of QI in spleen and stomach or pain, dyspepsia.Abdominal distention uncomfortable in chest, indigestion and loss of appetite loose stool in turbid damp resistance.Phlegm-damp is stopped up the cough and asthma of lung.For fullness in the epigastrium and chest, lack of appetite and vomiting, cough with copious phlegm.
The Rhizoma Pinelliae: acrid in the mouth, warm in nature;
Cure mainly: drying dampness to eliminate phlegm, stomach function regulating preventing or arresting vomiting, cures mainly phlegm-damp diseases caused by retention of fluid, vomiting, the diseases such as cough with asthma.
Flos Calystegiae sepii: (flower) is sweet, (root) is pungent, warm;
Cure mainly pathogenic cold in abdomen pathogenic heat gas (with root), on the face melanotic nevus.Also diuresis, reuniting the fractured tendons and bones, closes knife injury, controls erysipelas, mends strain, beneficial vital essence:
The Radix Paeoniae Alba: picric acid is cool;
Cure mainly: nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.Control the breast abdomen pain over the hypochondriac region, dysentery stomachache, spontaneous sweating, fever due to yin deficiency.
The Pseudobulbus Bletillae (Rhizoma Bletillae): bitter in the mouth, sweet, puckery, cold nature;
Cure mainly: astringing to arrest bleeding, detumescence and promoting granulation.For hemoptysis, spit blood, traumatic hemorrhage, sore swollen toxin, chapped skin; Pulmonary tuberculosis hemoptysis, ulcer haemorrhage.
In some embodiment, described Chinese medicine composition can be prepared as a kind of pharmaceutically acceptable preparation (carrier or excipient) through extracting, mixing therein; The preparation of described Chinese medicine composition, it is above-mentioned Chinese medicine composition and other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
In some embodiment, the mixture of the effective ingredient of described Chinese medicine composition after extracting, is prepared as a kind of pharmaceutically acceptable preparation (carrier or excipient) therein; The preparation of described Chinese medicine composition, it is the extract of above-mentioned Chinese medicine composition and other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
A kind of medicine for the treatment of cancer of pancreas of the present invention, by the multiple Chinese herbal medicine with anticancer function, formed, through with other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, be mainly used in the treatment of cancer of pancreas, there is rapid-action, good effect, the features such as taking convenience, and relatively there is with general chemicals the feature that toxic and side effects is little.The effect that it is anticancer, except showing effective anticancer, can also strengthen patient's immunity, improve hemorheology index, suppress oncogene expression, cancer cell specific induction of apoptosis, anticancer propagation, and can reduce patient's injury that normal structure is subject to when accepting the treatment meanss such as chemotherapy, radiotherapy, reduce the incidence rate of complication for patients, thereby improve the cure rate of Pancreas cancer patients, reduce the mortality rate of cancer of pancreas.
The specific embodiment
For further understanding feature of the present invention, technological means and the specific purposes that reach, function, resolve the advantages and spirit of the present invention, by embodiment below, the present invention is described further, embodiment is only used for explaining, and never means that it limits the scope of the invention by any way.
The Chinese medicine composition dosage with obvious antitumor action provided by the invention can suitably be adjusted according to the variations such as the order of severity of route of administration, patient individual difference, clinical application and disease, and the crude drug of Chinese medicine is comprised of the component of following weight parts proportioning:
260 parts of Semen Ziziphi Spinosaes, 105 parts of the Radixs Astragali, 105 parts of Radix Codonopsis, 70 parts of the Rhizoma Atractylodis Macrocephalaes, 105 parts of Semen Coicis core, 105 parts of Herba Hedyotidis Diffusaes, 84 parts, Poria, 84 parts of Fructus Akebiaes, 105 parts of Herba Scutellariae Barbataes, 84 parts of Herba Salviae Chinensiss, 70 parts of Radix Polygalaes, 21 parts, Radix Glycyrrhizae, 130 parts of Radix Bupleuris, 50 parts of Rhizoma Cyperis, 50 parts of Radix Curcumaes, 50 parts of Fructus Citri Sarcodactylis, 75 parts of Herba Lobeliae Chinensis, 50 parts of Rhizoma Corydalis, 30 parts of Rhizoma Chuanxiong, 16 parts of Pericarpium Citri Reticulataes, 110 parts of the Rhizoma Pinelliaes, 10 parts of Cortex Magnoliae Officinalis, 70 parts of Flos Calystegiae sepii, 30 parts of the Radix Paeoniae Albas, 70 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s.
Crude drug is obtained through pulverizing to extract to be mixed with by Chinese crude drug or its extract, and making pharmaceutical preparation is tablet, capsule, granule, pill etc.
Instructions about how to take medicine: warm water takes.One day 3 times, one time 6, a 0.3g ~ 1g, observes by the long-term follow of out-patient's 10 examples, transference cure, the no longer medication of 8 examples, cure rate is up to 80%.
Successful case:
Mr. Chen, 70 years old, more than in December, 2009 stomachache March, CT was diagnosed as cancer of pancreas.
More than 6 hours, intravenous injection developer is row whole body (basis cranii is to femur upper segment) PET-CT tomography after 1 hour on an empty stomach.
It is clear that examination scope develops, and contrast is good.
Right lobe of thyroid gland density is owed evenly, and has patch shape calcification shadow, metabolism no abnormality seen, and the pharyngeal tonsil in left side and throat muscle courseware symmetry developer are dense poly-, and SUVmax value is 5.5.Cervical region has no enlarged lymph node shadow and Developmental and Metabolic Disorder is active.In right lung, inferior lobe has little similar round and little strip high density shadow, the calcification of large portion, and left lung ligule also has similar change, and in mediastinum, aortic pulmonic window has small lymph node shadow, and metabolism is inactive.
The visible similar round watery density shadow of liver lobus sinister medial segment, diameter is 1.8cm.The slight active region of gastric antrum portion visible patch shape metabolism, is thought of as inflammatory lesion.
Pancreatic body afterbody increases, Density inhomogeneity, and profile is not whole and extend to pancreas rear, owes clearly with the boundary of neighbouring part blood vessel, and pathological changes Developmental and Metabolic Disorder is active, and SUVmax value is 5.6, the as seen less many lymph nodes shadow of respective regions posterior peritoneum, metabolism is comparatively active.
Patient, from 2010 06 month, takes medicine after half a year, and epigastrium not bitterly, is not told, and stomach, can normal diet continual cure also without uncomfortable.
Mr. Zhu, 66 years old, in May, 2012 CEA, the endoscopic endoscopic retrograde cholangiopancreatography (ERCP) of CA19-9 (ERCP), through liver puncture cholangiography (PTC).
There is colic symptoms in patient, intermittent dull pain is uncomfortable, with back part, radiates before 3 years, non-undulatory property, before half a year, symptom increases the weight of, and occurs whole body jaundice, stool is as kaolin, and urine is as black tea, whole skin pruritus, the food of not pursuing progress, abdominal pain and distension increases the weight of, and general weakness is gone to see a doctor, plan is examined the row stones in intrahepatic bile duct PTBD into cancer of pancreas ,Hou Dao hospital.Sb.'s illness took a favorable turn, be in hospital and leave hospital January, before first quarter moon, do CT examination finding: Diseases In Pancreatic Head is shown in the approximately Density inhomogeneity soft-tissue density piece shadow of 80 * 70mm of cross section, after enhancing, be the high strengthening of obvious heterogeneity, main pancreatic duct expansion, anal region is shown in the blood vessel of tortuous expansion, the summary low-density of seeing many places obscurity boundary in liver, is weak strengthening after enhancing, part lesion boundary is without abnormal strengthening, abdominal cavity is without hydrops, and intraperitoneal is shown in drainage catheter shadow.
Diagnosis: cancer of pancreas.
Patient is from October, 2012, and after the half a year of taking medicine, CT examination shows 40 * 60mm, and in also taking medicine at present, the state of an illness has clear improvement! Mr. Li, 69 years old, in November, 2012, the bimester of near, there was swollen sense in upper abdomen department, there is no appetite, health is empty, starts constipation, and stool was normal in the past, general power from head to foot, gastroscope is looked into the rotten to the corn gastritis of shallow, does gastroscope, B ultrasonic, electrocardiogram, electrocardio color ultrasound, blood test tumor full figure.Tumor full figure has been looked into a severe overweight: blood CA-199, ten punctures of PET-CF ultrasonic endoscope.
Big belly, discomfort, anorexia, becomes thin, swollen portion hydrops.
Diseases In Pancreatic Head is shown in that cross section is about 5 * 7cm, Density inhomogeneity, and soft-tissue density's piece shadow, is the high strengthening of obvious heterogeneity after enhancing.
Patient is from December, 2012, and patient took medicine after half a year, and sb.'s illness took a favorable turn, can normally be engaged in agriculture, and does not need to take that other is medicinal, drug withdrawal.
Mr. Li, 59 years old, the capable PET ﹣ of 2012-10-19 CT examination: uncinate process of pancreas Bu Jian soft-tissue density lump shadow, size is 2.1 * 1.1cm approximately, the about 5HU of CT value, PET video picture is shown in that abnormal radioactivity is dense poly-, SUVmax10.5, pancreatic tail atrophy.Ductus pancreaticus is obviously expanded, and head of pancreas is shown in several lymph node radioactivity gathering shadows around.Slightly low-density shadow of a nodositas is respectively seen by the right front leaf of liver and right lobe of liver fornix portion, and size is respectively 1.0cm and 1.1cm(right lobe of liver neoplasm metastasis).Two lung locality edema due to disorder of QIs, a plurality of stigma sheet tuberosity shadows in right lung, are low metabolism.The interior several lymph nodes of two hilus pulumonis mediastinums are hypermetabolism shadow slightly.
Patient, from November, 2012, takes medicine after three months, and sb.'s illness took a favorable turn, and the ,San Ge Yuehoudao hospital check that returns to one's perfect health, without recurrence, does not need to have taken medicine.
The Chinese medicine composition dosage with obvious antitumor action provided by the invention can suitably be adjusted according to the variations such as the order of severity of route of administration, patient individual difference, clinical application and disease, its every daily dose is counted 5g ~ 50g by crude drug, preferred every daily dose is 15g ~ 30g, can once or several times use.
The above embodiment has only expressed several embodiment of the present invention, and it describes comparatively concrete and detailed, but can not therefore be interpreted as the restriction to the scope of the claims of the present invention.It should be pointed out that for the person of ordinary skill of the art, without departing from the inventive concept of the premise, can also make some distortion and improvement, these all belong to protection scope of the present invention.Therefore, the protection domain of patent of the present invention should be as the criterion with claims.

Claims (4)

1. a Chinese medicine composition for the treatment of cancer of pancreas, is characterized in that, the crude drug of its Chinese medicine is comprised of the component of following weight parts proportioning:
240~270 parts of Semen Ziziphi Spinosaes, 100~115 parts of the Radixs Astragali, 100~115 parts of Radix Codonopsis, 65~80 parts of the Rhizoma Atractylodis Macrocephalaes, 100~115 parts of Semen Coicis core, 100~115 parts of Herba Hedyotidis Diffusaes, 75~85 parts, Poria, 75~85 parts of Fructus Akebiaes, 95~110 parts of Herba Scutellariae Barbataes, 75~85 parts of Herba Salviae Chinensiss, 60~75 parts of Radix Polygalaes, 20~25 parts, Radix Glycyrrhizae, 120~145 parts of Radix Bupleuris, 40~55 parts of Rhizoma Cyperis, 40~55 parts of Radix Curcumaes, 45~60 parts of Fructus Citri Sarcodactylis, 70~85 parts of Herba Lobeliae Chinensis, 45~60 parts of Rhizoma Corydalis, 25~30 parts of Rhizoma Chuanxiong, 14~19 parts of Pericarpium Citri Reticulataes, 100~115 parts of the Rhizoma Pinelliaes, 8~13 parts of Cortex Magnoliae Officinalis, 60~75 parts of Flos Calystegiae sepii, 28~35 parts of the Radix Paeoniae Albas, 65~80 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s.
2. a kind of Chinese medicine composition for the treatment of cancer of pancreas according to claim 1, is characterized in that, the crude drug of described Chinese medicine is comprised of the component of following weight parts proportioning:
260 parts of Semen Ziziphi Spinosaes, 105 parts of the Radixs Astragali, 105 parts of Radix Codonopsis, 70 parts of the Rhizoma Atractylodis Macrocephalaes, 105 parts of Semen Coicis core, 105 parts of Herba Hedyotidis Diffusaes, 84 parts, Poria, 84 parts of Fructus Akebiaes, 105 parts of Herba Scutellariae Barbataes, 84 parts of Herba Salviae Chinensiss, 70 parts of Radix Polygalaes, 21 parts, Radix Glycyrrhizae, 130 parts of Radix Bupleuris, 50 parts of Rhizoma Cyperis, 50 parts of Radix Curcumaes, 50 parts of Fructus Citri Sarcodactylis, 75 parts of Herba Lobeliae Chinensis, 50 parts of Rhizoma Corydalis, 30 parts of Rhizoma Chuanxiong, 16 parts of Pericarpium Citri Reticulataes, 110 parts of the Rhizoma Pinelliaes, 10 parts of Cortex Magnoliae Officinalis, 70 parts of Flos Calystegiae sepii, 30 parts of the Radix Paeoniae Albas, 70 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s.
3. a kind of Chinese medicine composition for the treatment of cancer of pancreas according to claim 1, is characterized in that, described Chinese medicine composition is through extracting, being mixed with as a kind of pharmaceutically acceptable preparation; The preparation of described Chinese medicine composition, it is above-mentioned Chinese medicine composition and other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
4. a kind of Chinese medicine composition for the treatment of cancer of pancreas according to claim 1, is characterized in that, the mixture of the effective ingredient of described Chinese medicine composition after extracting, is prepared as a kind of pharmaceutically acceptable preparation; The preparation of described Chinese medicine composition, it is the extract of above-mentioned Chinese medicine composition and other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
CN201310669009.7A 2013-12-11 2013-12-11 A kind of Chinese medicine composition for the treatment of cancer of pancreas Active CN103611091B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310669009.7A CN103611091B (en) 2013-12-11 2013-12-11 A kind of Chinese medicine composition for the treatment of cancer of pancreas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310669009.7A CN103611091B (en) 2013-12-11 2013-12-11 A kind of Chinese medicine composition for the treatment of cancer of pancreas

Publications (2)

Publication Number Publication Date
CN103611091A true CN103611091A (en) 2014-03-05
CN103611091B CN103611091B (en) 2016-04-27

Family

ID=50161824

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310669009.7A Active CN103611091B (en) 2013-12-11 2013-12-11 A kind of Chinese medicine composition for the treatment of cancer of pancreas

Country Status (1)

Country Link
CN (1) CN103611091B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104707110A (en) * 2015-04-09 2015-06-17 张妮 Traditional Chinese medicine preparation for treating pancreatic cancer and preparation method thereof
CN104958474A (en) * 2015-07-01 2015-10-07 张晓艳 Traditional Chinese medicine for treating damp heat stagnation type pancreatic cancer and preparation method thereof
CN104958594A (en) * 2015-07-02 2015-10-07 张云 Traditional Chinese medicine for qi and blood stasis stagnation type pancreatic cancer and preparation method thereof
CN105362606A (en) * 2015-12-24 2016-03-02 张云 Traditional Chinese medicine for treating liver depression and heat accumulation type pancreatic cancer in combination with chemical therapy and preparation method of traditional Chinese medicine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1772262A (en) * 2005-10-27 2006-05-17 吴军杰 Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process
CN101670071A (en) * 2009-09-25 2010-03-17 卢速江 Traditional Chinese medicine preparation for treating cancer and preparation method thereof
CN102008685A (en) * 2010-11-23 2011-04-13 高学哲 Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer
CN102641477A (en) * 2012-05-14 2012-08-22 许俊斋 Medicament for treating pancreatic cancer
CN102772745A (en) * 2012-08-21 2012-11-14 卢速江 Chinese medicinal preparation for treating cancer and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1772262A (en) * 2005-10-27 2006-05-17 吴军杰 Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process
CN101670071A (en) * 2009-09-25 2010-03-17 卢速江 Traditional Chinese medicine preparation for treating cancer and preparation method thereof
CN102008685A (en) * 2010-11-23 2011-04-13 高学哲 Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer
CN102641477A (en) * 2012-05-14 2012-08-22 许俊斋 Medicament for treating pancreatic cancer
CN102772745A (en) * 2012-08-21 2012-11-14 卢速江 Chinese medicinal preparation for treating cancer and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
何光鉴,陈仕凯: "晚期胰腺癌治验1例", 《成都中医药大学学报》, vol. 18, no. 04, 28 December 1995 (1995-12-28), pages 34 - 35 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104707110A (en) * 2015-04-09 2015-06-17 张妮 Traditional Chinese medicine preparation for treating pancreatic cancer and preparation method thereof
CN104958474A (en) * 2015-07-01 2015-10-07 张晓艳 Traditional Chinese medicine for treating damp heat stagnation type pancreatic cancer and preparation method thereof
CN104958594A (en) * 2015-07-02 2015-10-07 张云 Traditional Chinese medicine for qi and blood stasis stagnation type pancreatic cancer and preparation method thereof
CN105362606A (en) * 2015-12-24 2016-03-02 张云 Traditional Chinese medicine for treating liver depression and heat accumulation type pancreatic cancer in combination with chemical therapy and preparation method of traditional Chinese medicine

Also Published As

Publication number Publication date
CN103611091B (en) 2016-04-27

Similar Documents

Publication Publication Date Title
CN102342992B (en) Chinese medicinal composition for treating insomnia and preparation method of preparation thereof
CN103127433B (en) Chinese medicament for treating lung cancer and preparation method thereof
CN102526498B (en) Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof
CN103611091B (en) A kind of Chinese medicine composition for the treatment of cancer of pancreas
CN103550696B (en) Medicine for treating lung cancer
CN104984267A (en) Traditional Chinese medicine composition for treating lung cancer
CN103263587B (en) Traditional Chinese medicine preparation for treating toxic and side effects of nasopharyngeal carcinoma after radiotherapy and preparation method thereof
CN103432412B (en) Medicament for treating hyperplasia of mammary glands and preparation method thereof
CN103386024B (en) Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof
CN103028077B (en) Traditional Chinese medicine preparation for treating tumors
CN104623384A (en) Liver smoothing and qi regulating drug for treating mammary gland hyperplasia and preparation method of liver smoothing and qi regulating drug
CN104288745A (en) Traditional Chinese medicine for treating CG (Chronic Gastritis)
CN103463554A (en) Pharmaceutical composition for treating malignant tumor, preparation method and application
CN103920114A (en) Traditional Chinese medicinal composition for treating pulmonary fibrosis
CN104491447A (en) Compound medicine for treating gastrointestinal tract tumors
CN104800565B (en) A kind of Chinese medicine and preparation method for the treatment of esophageal carcinoma
CN104042766A (en) Traditional Chinese medicinal composition for treating habitual constipation
CN104042981A (en) Medicament for treating postnatal constipation and preparation method thereof
CN105999092A (en) Traditional Chinese medicine pill for treating melanosis coli
CN104998074A (en) Traditional Chinese medicine for treating gastropathy and preparation method thereof
CN104623605A (en) Traditional Chinese medicine capable of treating breast cancer
CN106822779A (en) A kind of Chinese medicine composition of the obstruction of qi in the chest and palpitation and insomnia for treating caused by energy stagnation and blood stasis
CN106266985A (en) A kind of can the pill medicine effectively treating hepatitis B and preparation method thereof
CN106215116A (en) A kind of Chinese medicine composition treating thyroid nodule
CN105288334A (en) Gastric cancer treatment medicine for oral administration and preparation method of gastric cancer treatment medicine for oral administration

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 523000 Guangdong province Dongguan City Wanjiang District Joint Village Second Industrial Zone No. 6 4 floor

Applicant after: DONGGUAN DONGZHUO ZHONGTIAN BIOTECHNOLOGY CO., LTD.

Address before: 523050 Guangdong province Dongguan City Wanjiang District Joint Village Second Industrial Zone No. 6 4 floor (Gary office building 4 floor) Dongguan Shenghong Biotechnology Co. Ltd.

Applicant before: DONGGUAN SHENGHONG BIOTECHNOLOGY CO., LTD.

COR Change of bibliographic data
C14 Grant of patent or utility model
GR01 Patent grant